2021 CMSC Annual Meeting

Tag: MPH3

Poster-Quality of Life and Outcomes

Understanding MS Symptoms and Impacts through Semi-Structured Interviews with Clinical Experts and People Living with MS

Background: Multiple sclerosis (MS) is a chronic progressive disease, affecting a broad range of important functions. In order to...

Read More

Poster-Epidemiology and Genetics

Baseline Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients Enrolling in the US-Based Corrona MS Registry

Background: An estimated 85% of persons with multiple sclerosis (MS) present with relapsing-remitting (RRMS) disease. There are few large...

Read More

Poster-Disease-modifying Therapy

Baseline Characteristics and Adherence Among Multiple Sclerosis Patients Initiating Siponimod in Real World

Background: Siponimod was approved in the United States (US) in March 2019 for patients with relapsing forms of Multiple Sclerosis (MS)....

Read More